Photo of Don Bacon
R United States House · District 2 · Nebraska

Rep. Don Bacon

Compare
Total votes
2,818
all sessions
Attendance
99%
21 missed
Higher than 90% of chamber peers
With party
88%
of cast votes
Lower than 87% of chamber peers
Bipartisan score
6%
crosses aisle rarely
Higher than 86% of chamber peers
Sponsored
2,348
bills & resolutions
Higher than 96% of chamber peers
Committees
6
assignments
2,348 bills and resolutions

Sponsored bills

Total
2,348
Primary
161
Co-sponsor
2,187
This page
2,348
matching current filters
Co-sponsor HR 1913
In committee · Delaware House · Co-sponsor
Uzbekistan Normalized Trade Act

Uzbekistan Normalized Trade Act This bill authorizes the President to extend nondiscriminatory treatment (i.e., normal trade relations treatment) to products of Uzbekistan.

In committee Mar 16, 2021 1 co-sponsor
Co-sponsor HR 1800
In committee · Delaware House · Co-sponsor
Women and Lung Cancer Research and Preventive Services Act of 2021

Women and Lung Cancer Research and Preventive Services Act of 2021 This bill requires the Department of Health and Human Services to conduct an interagency review of the status of women and lung cancer. The review must report on the status of existing research and current knowledge gaps; identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and provide recommendations for a national cancer screening strategy and public education campaign.

In committee Mar 12, 2021 1 co-sponsor
Co-sponsor HR 1819
In committee · Delaware House · Co-sponsor
Energizing American Shipbuilding Act of 2021

Energizing American Shipbuilding Act of 2021 This bill directs (1) the Federal Energy Regulatory Commission (FERC) to require specified percentages of liquefied natural gas exports to be transported on vessels built or retrofitted in the United States and documented under its laws, and (2) the President to require specified percentages of crude oil exports to be transported on vessels built or retrofitted in the United States and documented under its laws. FERC and the President may waive these requirements under specified circumstances. The Energy Information Administration must collect and publish information on exports of natural gas and crude oil by vessels, including forecasts and data on those exports.

In committee Mar 12, 2021 1 co-sponsor
Co-sponsor HR 1813
In committee · Delaware House · Co-sponsor
FASTER Act

Funding for Aviation Screeners and Threat Elimination Restoration Act or the FASTER Act This bill repeals the requirement that a portion of aviation security service fees collected from passengers be credited as offsetting receipts and deposited in the general fund of the Treasury. It requires such fees to be deposited into a separate account in the Treasury for expenditure to pay only the costs of activities and services for which the fee is imposed (i.e., aviation security screening).

In committee Mar 12, 2021 1 co-sponsor
Co-sponsor HR 1803
In committee · Delaware House · Co-sponsor
Youth Mental Health and Suicide Prevention Act of 2021

Youth Mental Health and Suicide Prevention Act of 2021 This bill authorizes the award of matching grants to enhance services in secondary schools for students with mental and behavioral health issues that can lead to failure in school, such as depression and substance abuse. The Substance Abuse and Mental Health Services Administration may award these grants on a competitive basis to state or local educational agencies that serve at least one secondary school.

In committee Mar 12, 2021 1 co-sponsor
Co-sponsor HR 1794
In committee · Delaware House · Co-sponsor
Foster Youth Dental Act of 2021

Foster Youth Dental Act of 2021 This bill expands Medicaid coverage of current and former foster youth, particularly with respect to dental services. Specifically, the bill requires state Medicaid programs to cover early and periodic screening, diagnostic, and treatment services, including dental services, for current and former foster youth under the age of 26. States must set a special payment rate, based on rates in the private sector, for dental services provided to such individuals; the bill provides an enhanced Federal Medical Assistance Percentage (i.e., federal matching rate) for excess expenses that result from such payments. The bill's requirements take effect 80 days after the date of enactment of the bill. The bill also accelerates the application of certain provisions that require a state Medicaid program to cover former foster youth from other states until the age of 26; such provisions currently apply to former foster youth who reach the age of 18 on or after January 1, 2023. The bill instead applies these provisions to former foster youth who reach the age of 18 on or after the date of enactment of the bill.

In committee Mar 12, 2021 1 co-sponsor
Co-sponsor HR 1745
In committee · Delaware House · Co-sponsor
Developing Responsible Individuals for a Vibrant Economy Act

Developing Responsible Individuals for a Vibrant Economy Act or the DRIVE-SAFE Act This bill directs the Department of Transportation to promulgate regulations to implement an apprenticeship program for licensed commercial motor vehicle drivers under the age of 21. Under the program, an apprentice must complete two probationary periods that total 400 hours of on-duty time, of which at least 240 hours must be driving time in a commercial motor vehicle. Additionally, the apprentice must be accompanied in the cab of the commercial motor vehicle by an experienced driver. Further, the bill requires all commercial motor vehicles used in the program for training to be equipped with safety technology such as active braking collision mitigation systems and video event capturing systems. An employer shall not knowingly allow, require, permit, or authorize a driver under the age of 21 to operate a commercial motor vehicle unless the driver is participating in, or has completed, an apprenticeship program that meets the requirements set forth in this bill.

In committee Mar 11, 2021 1 co-sponsor
Co-sponsor HR 1750
In committee · Delaware House · Co-sponsor
Child Welfare Provider Inclusion Act of 2021

Child Welfare Provider Inclusion Act of 2021 This bill generally prohibits the federal government, states, tribal nations, or localities from discriminating or taking adverse action against a child welfare provider that declines to provide services due to the provider's sincerely held religious beliefs or moral convictions. However, government entities may still take adverse action against a provider that declines to provide adoption or foster care services based on race, color, or national origin. The Department of Health and Human Services must withhold a portion of federal funding for family services and child welfare activities from a government entity that discriminates against a child welfare provider in violation of this bill. Child welfare providers may also sue the government entity for such discrimination. A prevailing provider may recover reasonable attorney's fees and costs. Furthermore, government entities that accept certain federal funding for family services and child welfare activities must waive sovereign immunity as a defense to lawsuits brought under this bill. (In many cases, sovereign immunity shields states, territories, tribal nations, and some localities against private suits.)

In committee Mar 10, 2021 1 co-sponsor
Co-sponsor HR 1730
In committee · Delaware House · Co-sponsor
Speeding Therapy Access Today Act of 2021

Speeding Therapy Access Today Act of 2021 This bill requires and authorizes various actions to accelerate the development of therapies for rare diseases. The Food and Drug Administration (FDA) shall establish the Intercenter Institute on Rare Diseases and Conditions. The institute shall (1) coordinate engagement with relevant stakeholders, (2) build the FDA's expertise in the review of medical products to treat rare diseases, (3) coordinate regulatory science initiatives related to rare diseases, (4) establish and implement a program to make recommendations to address challenges associated with developing medical products to treat rare diseases in an individual or in very small populations, (5) convene a stakeholder meeting to consider potential amendments to labels for medical products to treat rare diseases, and (6) establish and carry out a program to facilitate voluntary communication between the sponsors of such medical products and third-party payers (e.g., insurance companies). The bill also authorizes the FDA to make grants to assist in developing practices related to the development and production of individualized therapies or therapies to treat very small populations. The bill also establishes an advisory committee to advise the FDA on issues related to the development of therapies to treat rare diseases.

In committee Mar 10, 2021 1 co-sponsor
Showing 2,251 to 2,260 of 2,348 bills